| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e473613f549ad747f3af840e73fac8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 |
| filingDate |
2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf6b7040d135cfbf4808623d55e1654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1deb8b2a019b6e65e394190921d55f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec0ed68db9d24873f10c51c35a35e0cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5d882ed1bfc23cf01394e045279672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e74b61424334ee10b32496d02271205b |
| publicationDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021156828-A2 |
| titleOfInvention |
Biomarkers and uses thereof in the treatment of chronic hepatitis b infection |
| abstract |
Single nucleotide polymorphisms (SNPs) that are indicative of relapse after a HBV direct-acting antiviral agent (DAA) treatment, such as a NUC treatment in a chronic hepatitis B (CHB) infected subject are described. Also described are methods of using the SNPs in predicting the relapse in the HBV DAA treatment of CHB infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022049504-A3 |
| priorityDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |